Nalaganje...
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss
BACKGROUND: Hirudin is a potent thrombin inhibitor but its antithrombotic properties are offset by bleeding side-effects. Because hirudin’s N-terminus must engage thrombin’s active site for effective inhibition, fusing a cleavable peptide at this site may improve hirudin’s risk/benefit ratio as a th...
Shranjeno v:
| izdano v: | BMC Biotechnol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5887181/ https://ncbi.nlm.nih.gov/pubmed/29621998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12896-018-0431-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|